AFA-gen Capsules (Seroyal) – Microcystins Excess (2018)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice daily Dietary supplement 90 capsules, White 150cc HDPE Bottle with Desiccant and white cap, packed as 12 bottles / shipper case
Brand
Seroyal International, a division of Atrium Innovations
Lot Codes / Batch Numbers
Lot # 6E436-0, Product Code # 07596, Expiry Date: 09/2018
Products Sold
Lot # 6E436-0; Product Code # 07596; Expiry Date: 09/2018
Seroyal International, a division of Atrium Innovations is recalling Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules due to Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 6, 2026